KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Restructuring Costs (2016 - 2025)

Biogen (BIIB) has 12 years of Restructuring Costs data on record, last reported at $6.6 million in Q4 2025.

  • For Q4 2025, Restructuring Costs rose 24.53% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $48.6 million, up 60.93%, while the annual FY2025 figure was $48.6 million, 60.93% up from the prior year.
  • Restructuring Costs reached $6.6 million in Q4 2025 per BIIB's latest filing, down from $7.4 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $98.8 million in Q4 2023 and bottomed at -$700000.0 in Q2 2025.
  • Average Restructuring Costs over 4 years is $19.8 million, with a median of $7.2 million recorded in 2022.
  • Peak YoY movement for Restructuring Costs: soared 1311.43% in 2023, then plummeted 110.61% in 2025.
  • A 4-year view of Restructuring Costs shows it stood at $7.0 million in 2022, then skyrocketed by 1311.43% to $98.8 million in 2023, then crashed by 94.64% to $5.3 million in 2024, then grew by 24.53% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Restructuring Costs were $6.6 million in Q4 2025, $7.4 million in Q3 2025, and -$700000.0 in Q2 2025.